Suzanne Ildstad

Insider Reports History

Location
Wellesley, MA
Signature
/s/ Mary Kay Fenton, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Suzanne Ildstad:

Company Role Class Num Shares Value Price $ Report Date Ownership
Talaris Therapeutics, Inc. Director Common Stock 3,771,392 $64,075,950 $16.99 14 Jun 2023 Direct
Talaris Therapeutics, Inc. Director Common Stock 654,205 $11,114,943 $16.99 12 Jun 2023 Indirect
Talaris Therapeutics, Inc. Director Stock Option (Right to Buy) 20,500 13 Jun 2023 Direct

Insider Reports Filed by Suzanne Ildstad

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TALS Talaris Therapeutics, Inc. 12 Jun 2023 4 -$112,307 4 Director 14 Jun 2023, 18:58
TALS Talaris Therapeutics, Inc. 07 Jun 2023 3 -$342,504 4 Director 09 Jun 2023, 17:41
TALS Talaris Therapeutics, Inc. 05 Jun 2023 2 -$84,350 4 Director 07 Jun 2023, 18:24
TALS Talaris Therapeutics, Inc. 01 Jun 2023 2 -$79,793 4 Director 05 Jun 2023, 16:21
TALS Talaris Therapeutics, Inc. 21 Apr 2023 1 -$35,231 4 Director 25 Apr 2023, 17:50
TALS Talaris Therapeutics, Inc. 19 Apr 2023 2 -$156,369 4 Director 21 Apr 2023, 07:57
TALS Talaris Therapeutics, Inc. 17 Apr 2023 2 -$319,334 4 Director 19 Apr 2023, 09:22
TALS Talaris Therapeutics, Inc. 17 Mar 2023 1 -$21,543 4/A Director 07 Apr 2023, 16:25
TALS Talaris Therapeutics, Inc. 03 Mar 2023 1 -$13,992 4/A Director 07 Apr 2023, 16:23
TALS Talaris Therapeutics, Inc. 01 Mar 2023 1 -$59.45 4/A Director 07 Apr 2023, 16:21
TALS Talaris Therapeutics, Inc. 21 Feb 2023 1 -$7,185 4/A Director 07 Apr 2023, 16:19
TALS Talaris Therapeutics, Inc. 16 Feb 2023 2 -$13,446 4/A Director 07 Apr 2023, 16:17
TALS Talaris Therapeutics, Inc. 22 Aug 2022 1 -$1,470,000 4 Chief Scientific Officer 23 Aug 2022, 19:43
TALS Talaris Therapeutics, Inc. 01 Feb 2022 3 $0 4 Chief Scientific Officer 02 Feb 2022, 17:04